The federal government and thus largely Jens Spahn have ordered too little corona vaccine.
This criticism is currently being expressed more and more.
A Leopoldina member finds sharp words.
The vaccination campaign with the
corona vaccine from
the manufacturer
Biontech
started
last week
.
But the vaccines are initially in short supply - this triggers massive criticism of the
vaccination strategy
.
Federal
Minister of
Health
Jens Spahn in
particular
has to take a lot right now.
Berlin - There is criticism of
Health Minister Jens Spahn
.
Vaccinations have been taking place in Germany since last week.
It is the largest
vaccination campaign
that Germany has ever seen.
But the
corona vaccine from
the Mainz company
Biontech
in cooperation with
Pfizer
is scarce at the beginning.
This brings the vaccination strategy of Health Minister
Jens Spahn
into focus.
Questions get louder.
Will there be enough vaccine against the
coronavirus
soon
?
Also
BioNTech
founder
Ugur Sahin
was in amazement of the EU vaccine order with respect and told the
Mirror
: "Apparently, there was the impression we get enough, everything is not so bad, and we have that under control."
In the eye of the storm:
Jens Spahn
.
He was recently quite thin-skinned against criticism.
A member of the National Academy of Sciences
Leopoldina
makes serious accusations against the federal government.
“I consider the current situation to be a gross failure of those responsible,” said neurologist
Frauke Zipp
sharply to the newspaper
Welt
.
“Recently there was still official commemoration of the dead, now apparently not every day on which human lives could be saved counts anymore.
Now patience is required. "
Health Minister @jensspahn (CDU) explains why Germany did not single-handedly order vaccines from the start.
pic.twitter.com/HNrz0Tc3b7
- Report from Berlin (@ARD_BaB) December 30, 2020
Corona vaccination strategy: There is criticism of Federal Health Minister Spahn - also from Leopoldina
“Why didn't you order a lot more
risk
vaccine
in the summer
?” Added Zipp.
According
to their level of knowledge,
Biontech
offered significantly more vaccine doses in late summer.
The neurologist also stated that if there was enough
corona vaccine
in Germany,
vaccination
would be
possible within two or three months.
But the
criticism of Jens Spahn
comes not only from medical circles, but also from several political groups.
The FDP general secretary
Volker Wissing
referred to countries like
Israel
.
You can see from them that it is possible to vaccinate quickly.
"The criticism of the
vaccine procurement
is to be taken very seriously." The federal government must therefore explain very well why the vaccination of the population is so slow.
Why is vaccination starting so slowly in Germany and the EU?
Did the EU fail to order vaccines?
Not everything went well, but the alternatives were worse.
One thread 👇
- Stefan Leifert (@StefanLeifert) January 2, 2021
Criticism of Jens Spahn: The Left calls for a government declaration and a plan to increase the vaccination capacity
The fingers point to
Jens Spahn
, who, as Federal
Minister of
Health, is largely responsible for the
corona vaccination strategy
.
Left boss Bernd Riexinger
expressed himself
“a little surprised how few
vaccine doses the EU has
ordered.” It is now necessary to quickly
issue
licenses for the post-production of the
Biontech / Pfizer vaccine
.
That is Spahn's responsibility.
Even
Karl Lauterbach
(SPD) was critical and said they had shopped wrong.
Compared to
t-online
, SPD parliamentary
deputy Dirk Wiese
also referred in the direction of
Jens Spahn
: "As the minister responsible, he must finally do his job and get the obvious problems under control immediately."
The
Left Party
now wants
Spahn to
declare
himself
in the Bundestag.
"It must be worked out why the
vaccine is
too scarce and where it was sloppy," said the parliamentary group leader
Jan Korte
.
The health minister must also explain how
vaccination capacities
can be increased quickly.
(3/3) Germany has secured over 130 million cans for 2021 from BioNTech and Moderna alone.
In addition, as of today, approvals for the vaccines from AstraZeneca, Johnson & Johnson / Janssen and CureVac are likely in the course of the first quarter of 2021.
- BMG (@BMG_Bund) January 1, 2021
SPD calls for pharmaceutical summit: parliamentary group manager with harsh words - "a show event"
The
SPD parliamentary group is
calling for a
pharmaceutical summit on vaccine production
.
There Spahn had to clarify "which production facilities exist and can be made usable at short notice," said the parliamentary SPD parliamentary group leader
Carsten Schneider
.
"The Federal Minister of Health now has to end the chaos surrounding the delivery and distribution of the vaccine quickly." The question even arises as to whether the start of vaccinations in Germany was "a show event".
The real test for
Health Minister Jens Spahn
, it seems to have caught up with him now.
On January 2, he retweeted the
Twitter thread of the ZDF correspondent
in Brussels
on his Twitter profile
.
In it, the journalist addresses, among other things, whether the
EU has ordered too little vaccine
.
In one of the
tweets shared
by
Spahn
, he wrote: “No, rather too many.
The EU has secured 2 billion cans for 450 million EU citizens from 6 manufacturers.
Since it was not clear when the contract was signed in summer 2020 which vaccines would be the first to be marketable, the EU overordered. "However, he also states that the EU
could have ordered
more
corona vaccines
from
Biontech
and justified:" Since it was open at the time of the contract, The EU has ordered 200 million cans to determine whether Biontech is fast and successful.
Less than with other manufacturers, because
Biontech is
expensive (12 EUR / dose) and complicated (-70 ° cooling). "
On January 5th, the
Corona summit
by Chancellor
Angela Merkel
and the country leaders to deal with the Corona crisis is due.
According to the latest data from the Robert Koch Institute, around 165,000 people in Germany had been vaccinated against the corona virus by New Year.
(aka)
List of rubric lists: © Michael Sohn
